NCT04091087View on ClinicalTrials.gov

Study Evaluating Efficacy and Safety of Crisaborole in Adults With Stasis Dermatitis

PHASE2CompletedINTERVENTIONAL

Enrollment

66

Participants

Timeline

Start Date

June 26, 2020

Primary Completion Date

October 19, 2021

Study Completion Date

October 19, 2021

Conditions

Stasis Dermatitis

Interventions

DRUG

crisaborole ointment

crisaborole ointment

OTHER

vehicle ointment

vehicle ointment

Trial Locations (4)

40223

Onco360 Oncology Pharmacy, Louisville

90245

Lightship, El Segundo

94080

Verily Life Sciences LLC, South San Francisco

94549

Hawthorne Effect, Inc, Lafayette

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY